CN Patent

CN110475547A — 治疗多发性硬化症的组合物和方法

Assigned to Vitalis LLC · Expires 2019-11-19 · 6y expired

What this patent protects

本发明提供治疗多发性硬化症(MS)的组合物和方法。所公开的方法的一个实施方式向MS患者口服第一量的阿司匹林和第二量的富马酸或其酯或盐。在一些实施方式中，阿司匹林以每天约80 mg至约500 mg给药，富马酸或其酯或盐以每天约360 mg给药。

USPTO Abstract

本发明提供治疗多发性硬化症(MS)的组合物和方法。所公开的方法的一个实施方式向MS患者口服第一量的阿司匹林和第二量的富马酸或其酯或盐。在一些实施方式中，阿司匹林以每天约80 mg至约500 mg给药，富马酸或其酯或盐以每天约360 mg给药。

Drugs covered by this patent

monomethyl-fumarate (MONOMETHYL FUMARATE)

Patent Metadata

Patent number: CN110475547A
Jurisdiction: CN
Classification: —
Expires: 2019-11-19
Drug substance claim: No
Drug product claim: No
Assignee: Vitalis LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.